Clinical trial
Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine.
NCT00293657 · POZEN, Industry · Completed
Key facts
| NCT number | NCT00293657 |
|---|---|
| Title | Study of Lornoxicam or Placebo for Acute Treatment of the Headache of Migraine. |
| Official title | A Randomized, Double-Blind, Single-Dose Study, Placebo-Controlled Evaluation of the Safety and Efficacy of Intravenous Lornoxicam in the Acute Treatment of the Headache of Migraine. |
| Lead sponsor | POZEN, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Headache (Migraine) |
| Intervention type | Drug |
| Interventions | Lornoxicam 8 mg, Lornoxicam 16 mg, Placebo |
| Enrollment | 150 |
| Start date | Dec 1, 2005 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Feb 17, 2006 |
| Last update posted | Dec 3, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: